Clinical impact of coinfection with SARS-CoV-2, influenza virus, and respiratory syncytial virus among adults: a multicenter retrospective cohort study [2021-2025].

Xing Y, Bahl A

Open source

DOI
10.21037/jtd-2025-1-2682
Published
2026 Apr 30
Container
Journal of thoracic disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/jtd-2025-1-2682,
  title = {Clinical impact of coinfection with SARS-CoV-2, influenza virus, and respiratory syncytial virus among adults: a multicenter retrospective cohort study [2021-2025].},
  author = {Xing Y and Bahl A},
  year = {2026},
  journal = {Journal of thoracic disease},
  doi = {10.21037/jtd-2025-1-2682},
  url = {https://doi.org/10.21037/jtd-2025-1-2682}
}

RIS

TY  - JOUR
TI  - Clinical impact of coinfection with SARS-CoV-2, influenza virus, and respiratory syncytial virus among adults: a multicenter retrospective cohort study [2021-2025].
AU  - Xing Y
AU  - Bahl A
PY  - 2026
JO  - Journal of thoracic disease
DO  - 10.21037/jtd-2025-1-2682
UR  - https://doi.org/10.21037/jtd-2025-1-2682
ER  - 

APA

Y, X., & A, B. (2026). Clinical impact of coinfection with SARS-CoV-2, influenza virus, and respiratory syncytial virus among adults: a multicenter retrospective cohort study [2021-2025].. Journal of thoracic disease. https://doi.org/10.21037/jtd-2025-1-2682

Source records